English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 863747      Online Users : 810
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version

    Category

    Loading community tree, please wait....

    Year

    Loading year class tree, please wait....

    Items for Author "Chao, Y" 

    Return to Browse by Author

    Showing 84 items.

    Collection Date Title Relation Bitstream
    [其他] 會議論文/會議摘要 2021-07 Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma -
    [其他] 期刊論文 2020-06-30 Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response -
    [其他] 期刊論文 2019-12 Combined microsatellite instability and elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) might be a more promising immune biomarker in colorectal cancer -
    [其他] 期刊論文 2008-02 Good nursing: Perspectives of patients and family -
    [其他] 期刊論文 2007-08 Good nursing from the perspective of nurses -
    [其他] 期刊論文 2007-06 Perspectives on body: Embodiment and body image -
    [劉士任] 期刊論文 2005-03 Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma -
    [劉滄梧] 期刊論文 2006-11 Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma -
    [夏興國] 期刊論文 2013-05 Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase -
    [姜乃榕] 會議論文/會議摘要 2023-06 Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors -
    [姜乃榕] 會議論文/會議摘要 2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma -
    [姜乃榕] 期刊論文 2023-04 Elevated PD-L1 expression and microsatellite instability in elderly patients with gastric cancer -
    [張俊彥] 會議論文/會議摘要 2004-08-02 Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer -
    [彭汪嘉康(1996-2007)] 會議論文/會議摘要 1998-11 Clinical trials of HCC in Taiwan -
    [彭汪嘉康(1996-2007)] 期刊論文 2010-09 A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients -
    [彭汪嘉康(1996-2007)] 期刊論文 2009-12 Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent -
    [彭汪嘉康(1996-2007)] 期刊論文 2008-06 Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma -
    [彭汪嘉康(1996-2007)] 期刊論文 2005-08-01 alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma -
    [彭汪嘉康(1996-2007)] 期刊論文 2003-12 Spider angiomas in patients with liver cirrhosis: Role of vascular endothelial growth factor and basic fibroblast growth factor -
    [彭汪嘉康(1996-2007)] 期刊論文 2002-07 Palliative meflep therapy in advanced pancreatic cancer: Excellent response in a patient with her-2/neu amplification -
    [彭汪嘉康(1996-2007)] 期刊論文 2002-05 Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients -
    [彭汪嘉康(1996-2007)] 期刊論文 2000-05 Integration of computer-assembled digital images and text data as evidence for the oncological record -
    [彭汪嘉康(1996-2007)] 期刊論文 1999-07 A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells -
    [彭汪嘉康(1996-2007)] 期刊論文 1998-07 Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections -
    [彭汪嘉康(1996-2007)] 期刊論文 1996-12-20 Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide -
    [彭汪嘉康(1996-2007)] 期刊論文 1996-07-17 Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region -
    [徐祖安] 會議論文/會議摘要 2011-09 Overcoming the acquired resistance to Afatinib (BIBW2992) in HCC827, a non-small cell lung cancer cell line -
    [楊奕馨] 期刊論文 2021-11-30 Survival outcomes of management in metastatic gastric adenocarcinoma patients -
    [楊文光(1996-1999)] 期刊論文 1999-03 Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase -
    [楊文光(1996-1999)] 期刊論文 1999 Gene therapy with tumor vaccine increases the survival of hepatoma- bearing mice -
    [楊文光(1996-1999)] 期刊論文 1998-05-25 S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with Herpes simplex virus thymidine kinase -
    [蕭金福] 會議論文/會議摘要 2019-05 An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14) -
    [蕭金福] 會議論文/會議摘要 2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial -
    [蕭金福] 會議論文/會議摘要 2015-05 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial -
    [蕭金福] 期刊論文 2020-05 An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas -
    [蕭金福] 期刊論文 2018-07 The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients -
    [蕭金福] 期刊論文 2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial -
    [陳仁焜] 期刊論文 2022-04-10 Compassionate treatment of brainstem tumors with boron neutron capture therapy: A case series -
    [陳仁焜] 期刊論文 2021-04-15 Salvage boron neutron capture therapy for malignant brain tumor patients in compliance with emergency and compassionate use: Evaluation of 34 cases in Taiwan -
    [陳立宗] 會議論文/會議摘要 2020-02 A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data -
    [陳立宗] 會議論文/會議摘要 2019-02 Evaluation of efficacy of nivolumab by baseline factors from ATTRACTION-2 -
    [陳立宗] 會議論文/會議摘要 2018-09 Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials -
    [陳立宗] 會議論文/會議摘要 2018-05 Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials -
    [陳立宗] 會議論文/會議摘要 2018-02 Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials -
    [陳立宗] 會議論文/會議摘要 2017-09 A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02) -
    [陳立宗] 會議論文/會議摘要 2017-02 Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial -
    [陳立宗] 會議論文/會議摘要 2016-05 Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) -
    [陳立宗] 會議論文/會議摘要 2014-05 Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad -
    [陳立宗] 會議論文/會議摘要 2014-01 Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial -
    [陳立宗] 會議論文/會議摘要 2013-05 KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial -
    [陳立宗] 會議論文/會議摘要 2011-09 Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers -
    [陳立宗] 會議論文/會議摘要 2011-02 Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers -
    [陳立宗] 會議論文/會議摘要 2011-02 Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma -
    [陳立宗] 會議論文/會議摘要 2009-12 A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma -
    [陳立宗] 會議論文/會議摘要 2008-05 Cost-minimization analysis of capecitabine for advanced gastric cancer in Taiwan -
    [陳立宗] 會議論文/會議摘要 2008-05 Pharmacoeconomic analysis of capecitabine for advanced gastric cancer in Taiwan -
    [陳立宗] 會議論文/會議摘要 2008 Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment -
    [陳立宗] 會議論文/會議摘要 2007-09 A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer -
    [陳立宗] 會議論文/會議摘要 2005-06 An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report -
    [陳立宗] 會議論文/會議摘要 2002 Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma -
    [陳立宗] 期刊論文 2023-08 The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study -
    [陳立宗] 期刊論文 2022-10 Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study -
    [陳立宗] 期刊論文 2022-01 Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study -
    [陳立宗] 期刊論文 2021-07 Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab -
    [陳立宗] 期刊論文 2020-05 A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data -
    [陳立宗] 期刊論文 2020-01 Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer -
    [陳立宗] 期刊論文 2019-06-21 Identification of phenothiazine as an ETV1targeting agent in gastrointestinal stromal tumors using the Connectivity Map -
    [陳立宗] 期刊論文 2018-06 Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma -
    [陳立宗] 期刊論文 2017-12 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial -
    [陳立宗] 期刊論文 2016-05-03 Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer -
    [陳立宗] 期刊論文 2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer -
    [陳立宗] 期刊論文 2014-07 Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer -
    [陳立宗] 期刊論文 2013-06-21 A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma -
    [陳立宗] 期刊論文 2011-08-17 A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan -
    [陳立宗] 期刊論文 2010-10 A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer -
    [陳立宗] 期刊論文 2008 Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis -
    [陳立宗] 期刊論文 2006-07-17 An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer -
    [陳立宗] 期刊論文 2006-03 Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer -
    [陳立宗] 期刊論文 2001-03 Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis -
    [黃智興] 期刊論文 2004-09 Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies -
    [黃智興] 期刊論文 2004-01 A G-quadruplex ligand 3,3 '-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells -
    [黃智興] 期刊論文 2000-06 Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells -
    [黃智興] 期刊論文 1999-05-03 Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells -
    [黃智興] 期刊論文 1998-03-01 Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma -

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback